Search

Search Constraints

You searched for: Author/Creator Fayad, Luis E.

Search Results

1. A randomized, phase 2 study of R-CHOP plus enzastaurin vs R-CHOP in patients with intermediate- or high-risk diffuse large B-cell lymphoma. Issue 1 (2nd January 2016)

2. Additional therapy improves outcomes in completely resected, limited-stage follicular lymphoma. Issue 13 (10th November 2019)

3. Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma. Issue 12 (December 2013)

4. De novo CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era. Issue 2 (28th January 2020)

5. Dose adjusted‐EPOCH‐R and mediastinal disease may improve outcomes for patients with gray‐zone lymphoma. (5th July 2016)

7. Double hit lymphoma: the MD Anderson Cancer Center clinical experience. (18th June 2014)

8. Early‐stage Hodgkin lymphoma outcomes after combined modality therapy according to the post‐chemotherapy 5‐point score: can residual pet‐positive disease be cured with radiotherapy alone?. (18th August 2017)

9. Frontline antibiotic therapy for early‐stage Helicobacter pylori‐negative gastric MALT lymphoma. Issue 6 (6th March 2019)

10. Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapy. (November 2021)